Are you Mary Jo Smrekar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Publications & Presentations
PubMed
- 12 citationsA phase I study of oral topotecan and pegylated liposomal doxorubicin (doxil) in platinum-resistant ovarian and peritoneal cancer.Peter G. Rose, Mary Smrekar, Pam Haba, Nancy Fusco, Michael Rodriguez
American Journal of Clinical Oncology. 2008-10-01 - 20 citationsA phase I/II trial of weekly topotecan and carboplatin in potentially platinum-sensitive relapsed ovarian and peritoneal carcinoma.Peter G. Rose, Mary Smrekar, Pamela Haba, Christina Visser, John F. Beeler
Gynecologic Oncology. 2005-12-01 - 28 citationsA phase II trial of weekly paclitaxel and every 3 weeks of carboplatin in potentially platinum-sensitive ovarian and peritoneal carcinoma.Peter G. Rose, Mary Smrekar, Nancy Fusco
Gynecologic Oncology. 2005-02-01
Office
11231 Handlebar Rd
Reston, VA 20191Phone+1 703-391-1114Fax+1 703-391-7177
